United States

Showing 61-70 of 353 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Evaluating the Effectiveness and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 1 Diabetes	Emory University	Piaopiao Li	Improving Lives	01-July-2025 to 30-June-2027	$599,998.91
ENCRT-hPI (Immune-Protected ENCRT Extension Study), Evaluation of an immune-protected ENCRT-101 loaded with primary human islets in adults with Type 1 Diabetes, with and without standard-of-care portal vein islet infusion.	Encellin	Crystal Nyitray	Cures	25-June-2026 to 24-June-2028	$2,500,000.00
Stromal Cell Targeted Tolerogenic mRNA Therapy for T1D	Endotope Biosciences	Raymond Liang	Cures	15-December-2025 to 14-December-2027	$550,417.82
Subcutaneous In Vivo Engraftment and Vascularization of 3D Bioprinted Pancreatic-Like Tissue	FluidForm Bio	Adam Feinberg	Cures	23-December-2025 to 12-June-2026	$228,696.00
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population	Geisinger Clinic	David Carey	Cures	01-November-2022 to 30-September-2026	$1,469,640.10
GNTI-122 for the treatment of recently diagnosed type 1 diabetes	GentiBio	Mark Bach	Cures	01-February-2025 to 13-February-2028	$4,000,000.00
A Novel Magnetorheological Insulin Pump	Georgia Southern University Research and Service Foundation, Inc	Sevki Cesmeci	Improving Lives	01-June-2023 to 31-May-2026	$197,860.17
Synthetic Hydrogels for Islet Vascularization and Engraftment	Georgia Tech Research Corporation	Andres Garcia	Cures	01-July-2022 to 30-June-2026	$563,235.05
Hydrogels for Islet Engraftment in the Porcine Subcutaneous Space	Georgia Tech Research Corporation	Andres Garcia	Cures	01-November-2025 to 31-October-2028	$771,544.57
Rewiring Cellular Microenvironments with Synthetic Circuits for Subcutaneous Islet Transplantation	Georgia Tech Research Corporation	Alexander Vlahos	Cures	01-March-2026 to 28-February-2031	$992,325.06